Have a personal or library account? Click to login
Survey of U.S. Critical Care Practitioners on Net Ultrafiltration Prescription and Practice Among Critically Ill Patients Receiving Kidney Replacement Therapy Cover

Survey of U.S. Critical Care Practitioners on Net Ultrafiltration Prescription and Practice Among Critically Ill Patients Receiving Kidney Replacement Therapy

By: Huiwen Chen and  Raghavan Murugan  
Open Access
|Nov 2021

Figures & Tables

Fig.1

Reported Criteria Used for Initiating Fluid Removal
Reported Criteria Used for Initiating Fluid Removal

Fig.2

Reported Interventions Performed for Hemodynamic Instability During Net Ultrafiltration
Reported Interventions Performed for Hemodynamic Instability During Net Ultrafiltration

Fig.3

Perceived Barriers to Net Ultrafiltration
Perceived Barriers to Net Ultrafiltration

Attitudes Toward Timing, Use of a Protocol and Willingness to Enroll Patients in a Clinical Trial of Protocol-based Net Ultrafiltration

CharacteristicNo. (%)P value
All (N=465)Physician (N=196)Nurse & Nurse Practitioners (N=269)
I believe early fluid removal is beneficial
      Strongly agree148 (31.8)56 (28.6)92 (34.2)
      Agree195 (41.9)68 (34.7)127 (47.2)
      Somewhat agree71 (15.3)42 (21.4)29 (10.8)
      Neither agree nor disagree37 (8.0)19 (9.7)18 (6.7)<0.001
      Somewhat disagree7 (1.5)6 (3.1)1 (0.4)
      Disagree3 (0.6)2 (1.0)1 (0.4)
      Strongly disagree4 (0.9)3 (1.5)1(0.4)

I believe a protocol-based fluid removal strategy would be beneficial
      Strongly agree Agree113 (24.4) 160 (34.6)28 (14.3) 60 (30.6)85 (31.5) 100 (37.2)
      Somewhat agree108 (23.3)57(29.1)51 (20.0)<0.001
      Neither agree nor disagree52 (11.2)33 (16.8)19 (7.1)
      Somewhat disagree18 (3.9)9 (4.6)9 (3.3)
      Disagree11 (2.4)7 (3.6)4 (1.5)
      Strongly disagree3 (0.6)2 (1.0)1 (0.4)

I would enroll my patient in a clinical trial comparing protocol-basedversus usualcare
      Strongly agree108 (23.2)46 (23.5)62 (23.0)0.001
      Agree168 (36.1)84 (42.9)84 (31.2)
      Somewhat agree52 (11.2)24 (12.2)28 (10.4)
      Neither agree nor disagree107 (23.0)26 (13.3)81 (30.1)
      Somewhat disagree4 (0.9)3 (1.5)1 (0.4)
      Disagree15 (3.2)9 (4.6)6 (2.2)
      Strongly disagree9 (1.9)4 (2.0)5 (1.9)

Hemodynamic Management and Perceived Barriers to Net Ultrafiltration

CharacteristicNo. (%)
P value
All (n=465)Physician (n=196)Nurse & Nurse Practitioners (n=269)
Percentage of patients developing new hemodynamic instability during UFNET median (IQR)25.0 (10.0-100.0)25.0 (13.2-35.0)20.5 (10.0-50.0)0.79

interventions performed for hemodynamic instabilitya
      Decrease the rate of fluid removal331 (71.2)128 (65.3)203 (75.5)0 .02
      Completely stop fluid removal206 (44.3)93 (47.4)113 (43)0.24
      Make no changes to fluid removal rate17 (3.7)11 (5.6)6 (2.2)0.05
      Administer fluid bolus133 (28.6)51 (26)82 (30.5)0.29
      Start or increase the dose of a vasopressor263 (56.6)93 (47.4)170 (63.2)<0.001
      Switch to alternative modality26 (5.6)14 (7.1)12 (4.5)0.21
      Administer albumin or mannitol bolus157 (33.8)56 (28.6)101 (37.5)0.04

Perceived barriersa
      Patient intolerance (e.g., hypotension)371 (79.8)156 (80.0)215 (79.9)0.93
      Under prescription83 (17.8)32(16.3)51 (19.0)0.47
      Frequent interruptions (e.g., trip to CT scan, operating room, filter clotting, catheter malfunction)233 (50.1)96 (49.0)137 (50.9)0.67
      Inability to titrate fluid removal47 (10.1)24 (12.2)23 (8.6)0.19
      Unavailability of adequately trained nursing staff79 (17.0)28 (14.3)51 (19.0)0.18
      Unavailability of dialysis machines40 (8.6)27 (13.8)13 (4.8)0.001
      Cost associated with treatment11 (2.0)5 (2.5)6 (3.1)0.83

Characteristics of U_S_ Survey Respondents and Practice of Net Ultrafiltration

CharacteristicNo. (%)
P value
All (n=465)Physician (n=196)Nurse & Nurse Practitioner (n=269)
Years of practice, median (IQR)8.7 (4.2-19.4)8.8 (4.4-16.7)8.7 (4.1- 21.0)0.41
      Hospital typea
      University-based295 (64.8)128 (66.3)167 (63.7)
      Community-based140 (30.8)50 (25.9)90 (34.4)0.003
      Government20 (4.4)15(7.7)5(1.5)

Maximum dose of loop diuretic in milligrams equivalent to furosemide dosing before determining diuretic resistance, mgs/dayb
      <10010 (4.8)8 (4.4)2(8)
      100-250131 (63.0)114(62.3)17 (68)
      251-50053 (25.5)50 (27.3)3 (12)0.30
      501-7504(1.9)4(2.2)0
      <751-10009 (4.3)6 (3.3)3 (12)
      >10001 (0.5)1 (0.55)0

Criteria for initiating fluid removalb,c
      Cumulative fluid balance (i.e., >1000 mL)14 (7.4)13 (7.8)1 (4.3)
      Fluid overload>10% of body weight10 (5.3)9 (5.4)1 (4.3)
      Ongoing need for fluid administration in the presence of oliguria19 (10.0)18 (10.8)1 (4.3)0.72
      Persistent oliguria or anuria (i.e., urine output <0.5ml/kg/h for >12 hours)55 (28.9)49 (29.4)6 (26.1)
      Pulmonary edema with or without hypoxemia28 (14.7)25 (15.0)3 (13.0)
      Severe hypoxemia (i.e., PaO2/FiO2 ratio < 150)64 (33.7)53 (31.7)11 (47.8)

Criteria used for prescribing UFNETb,c
      24-hour fluid balance21 (10.6)20 (11.5)1 (4.2)
      Cumulative fluid balance since ICU admission24 (12.1)23 (13.2)1 (4.2)
      Hemodynamic status (i.e., HR, BP, CVP, PPV, dose of vasopressors) Radiographic features suggestive of fluid overload141 (71.2) 6 (3.0)121 (69.5) 5(2.9)20 (83.3) 1 (4.2)0.61
      Volume of anticipated fluid administration in the next 24 hours1 (0.5)1 (0.6)0
      Weight gain since ICU admission5(2.5)4(2.3)1 (4.2)

Intermittent hemodialysis, median (IQR)
      Percent use last month10.0 (2.2-30.0)10.0 (5.0-30.0)10.0 (2.0-30.0)0.29
      Typical prescription, liters per session2.0 (2.0-3.0)2.0 (2.0-3.0)2.0 (1.6-2.4)0.07

Slow forms of IHD, median (IQR)
      Percent use last month1.0 (1.0-15.0)2.0(0-23.0)1.0(0-10.5)0.08
      Typical prescription, liters per session2.0 (1Ό-2.5)2.0 (1.0-2.5)2.0 (1.2-2.4)0.17

Percent of assessment of prescribed-to- delivered dose, median (IQR)90.0(20.0-100.0)90.0 (50.0-100.0)72.5 (2.7-100.0)0.02

CKRT, median (IQR)
      Percent use last month60.0 (20.0-90.0)80.0(50.0-90.0)50.0(10.0-80.0)<0.001
      Initial UFNET rate for hemodynamically stable patient, mL per hour100.0 (79.0-200.0)100.0 (100.0-197.0)100.0(52.0-200.0)0.96
      Maximal UFNET rate for hemodynamically stable patient, ml per hour285.0(200.0-341.0)298.0 (200.0-351.0)253.5 (200.0-310.5)0.22
      UFNETrate for hemodynamically unstable patient, ml per hour51.0(25.0-100.0)52.0 (49.0-100.0)51.0 (10.0-100.0)0.91

Method used to achieve UFNET d
      By varying ultrafiltration rate only205 (61.9)75 (54.3)130(67.4)
      By varying replacement fluid rate only13 (3.9)8 (5.8)5(2.6)0.04
      By varying both ultrafiltration and replacement fluid rate113 (34.1)55(39.9)58 (30.1)

How frequently did you check net fluid balancee
      1 hour211 (58.2)43 (28.7)168 (79.2)
      2 hours19 (5.2)10(6.7)9 (4.2)
      4 hours34 (9.4)24 (16.0)10 (4.7)
      6 hours13 (3.6)11 (7.3)2 (0.9)<0.001
      8 hours16 (4.4)9 (6.0)7(3.3)
      12 hours34 (9.4)24 (16.0)10 (4.7)
      24 hours35 (9.7)29 (19.3)6(2.8)
DOI: https://doi.org/10.2478/jccm-2021-0034 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 272 - 282
Submitted on: Mar 11, 2021
|
Accepted on: Aug 24, 2021
|
Published on: Nov 6, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Huiwen Chen, Raghavan Murugan, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.